Abstract:Parkinson's disease (PD) has been recently associated with the excessive expression of matrix metalloproteinase 3 (MMP3). One of the major challenges in treating PD is to effectively detect and inhibit the early MMP3 activities to relieve the neural stress and inflammation responses. Previously, numerous upconversion nanoparticle (UCNP)-based nanoprobes have been designed for the detection of biomarkers in neurodegenerative diseases. To further improve the performance of the conventional nanoprobes, we introduced novel reporting units and integrated the therapeutic reagents to fabricate a theragnostic platform for PD and other neurodegenerative diseases. Here, we designed a multifunctional UCNP/aggregation-induced emission luminogen (AIEgen)-based nanoprobe to effectively detect the time-lapse MMP3 activities in the inflammatory catecholaminergic SH-SY5Y cells and simultaneously deliver the MMP3-siRNA into the stressed catecholaminergic SH-SY5Y cells, inhibiting the MMP3-induced inflammatory neural responses. The unique features of our UCNP/AIEgen-based nanoprobe platform shed light on the development of a novel theragnostic probe for the early diagnosis and cure of neurodegenerative diseases.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c22112?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c22112</a>.Concentrations of the staining reagents, quantification method of fluorescence intensity, detection of MMP3 enzyme activity by AIEgen-peptide reporting units in PBS, FTIR spectra of the nanoprobe, size stability and MMP3 detection ability of the nanoprobe in biological environments, MMP detection in PBS and serum, western blotting results, examination of the Hemi-Parkinsonian mouse model after 6-OHDA injection,, and the sequences of PD-related primers and siRNA applied in the experiments (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c22112/suppl_file/am0c22112_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A Small‐Molecule Probe for Selective Profiling and Imaging of Monoamine Oxidase B Activities in Models of Parkinson’s Disease

A Small-Molecule Probe For Selective Profiling And Imaging Of Monoamine Oxidaseb Activities In Models Of Parkinson'S Disease

An activity-based fluorogenic probe for sensitive and selective monoamine oxidase-B detection.

A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson’s disease models

Visualization of monoamine oxidases in living cells using &quot;Turn-ON&quot; fluorescence resonance energy transfer probes.

Structure-Based Specific Detection And Inhibition Of Monoamine Oxidases And Their Applications In Central Nervous System Diseases

Activatable Organic Upconversion Nanoprobe for Bioimaging of Monoamine Oxidase B in Parkinson's Disease

Monoamine oxidase A probe synthesis and fluorescence imaging in cells and zebrafish based on AIE mechanism

Activity-Based Probes for Studying the Activity of Flavin-Dependent Oxidases and for the Protein Target Profiling of Monoamine Oxidase Inhibitors

Ratiometric Near-Infrared Fluorescent Probe for Synergistic Detection of Monoamine Oxidase B and Its Contribution to Oxidative Stress in Cell and Mice Aging Models

Recent advances of small molecule fluorescent probes for distinguishing monoamine oxidase-A and monoamine oxidase-B in vitro and in vivo

Mitochondria targeting fluorescent probe for MAO-A and the application in the development of drug candidate for neuroinflammation

Computational Fragment-Based Design Facilitates Discovery of Potent and Selective Monoamine Oxidase-B (MAO-B) Inhibitor

Specific tracking of monoamine oxidase A in heart failure models by a far-red fluorescent probe with an ultra large Stokes shift

A dual target molecular magnetic resonance imaging probe for noninvasive profiling of pathologic alpha-synuclein and microgliosis in a mouse model of Parkinson's disease

An in situ fluorescent copolymer dots-based kit for the specific detection of monoamine oxidase-A in cell/tissue/human prostate cancer

Multifunctional Nanoprobe for the Delivery of Therapeutic siRNA and Real-Time Molecular Imaging of Parkinson’s Disease Biomarkers

Molecular Imaging of Enzyme Activity in Vivo Using Activatable Probes

Discovery of MAO-B Inhibitor with Machine Learning, Topomer CoMFA, Molecular Docking and Multi-Spectroscopy Approaches.

Identification of new small molecule monoamine oxidase-B inhibitors through pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation studies

Highly Deformable Double‐Sided Neural Probe with All‐in‐One Electrode System for Real‐Time In Vivo Detection of Dopamine for Parkinson's Disease (Adv. Funct. Mater. 4/2024)